Theme: Targeted drug delivery – Approaches for objectifying the target

Pharma 2017

Pharma 2017

Conference Series LLC invites all the participants from all over the world to attend ‘8th Annual Global Pharma Summit’ during Aug 17-18, 2017 San Francisco, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharma-2017 is a global conclave to discuss and learn about the sessions viz.,Pharmaceutical Preformulation, Novel Drug Delivery Systems, Pharma Nanotechnology, Clinical Pharmacy, Pharmacology and Toxicology, Pharmacognosy and Phytochemistry, Pharmacy Practice, Medicinal Chemistry, Industrial Pharmacy, Regulatory Authorities, Bio and Chemoinformatics, Market analysis and Business Oppurtunity.

Track1: Pharmaceutical Preformulation

Preformulation studies track of the Global Pharma Summit involves the focus on characterization of a drug's physical, chemical, and mechanical properties so as to assess the ingredients in the formulation. Global pharma companies are mainly focussing on the studies drug stability, and the compatibility with the drug excipients to eliminate the difficulties in the formulation. The analytical features of the drug and the excipients used in the making should be emphasized with the type of interfaces that might be likely in which analytical methods and evaluation are beneficial. Polymorphism is a particular distinctive that is to be measured preceding to formulation, in order to select the type of device and other limitations this character of the drug and excipients play a vital role.

Track 2: Novel Drug Delivery Systems

Drug delivery denotes to methods, preparations, skills, and structures for transferring a drug composite in the body as needed to safely achieve its preferred therapeutic efficacy. It may include methodical site-targeting inside the body, or it might involve enabling systemic Pharmacokinetics. Drug delivery skills amend drug release profile, absorption, distribution and elimination for the advantage of refining product effectiveness and safety, as well as patient suitability and compliance. This conference of Global Pharma Congress is going to mainly show the challenges in attainment of the novel drug delivery systems. These strategies sometimes may be in vivosystems like the Red blood cells also which are called as Resealed Erythrocytes or certain types of lipids as carriers which constitute the Liposomes, Niosomes, Nanoparticles, Nanospheres, Resealed Erythrocytes, Ethosomes etc., even the proteins and nucleotides may be used as potential carriers for molecular drug design. The route of drug delivery also concern as the Oral DDS< Parenteral DDS in relation to the absorption rate and to the degree the targeted devices also play a significant role in gaining more drug to site of action.

Track 3: Pharma Nanotechnology

Nanotechnology as determined by size is in a extensive logic, including grounds of science as different as outward science, micro fabrication. The associated examination and demonstrations are similarly varied, changing from extensions of conventional device physics to completely new approaches based upon molecular self-assembly, from growing innovative materials with dimensions on the Nano scale to direct control of substance on atomic scale implied by extreme reduction of particle size and collective area uncovered. Bio computing is the structure and use of computers that functions like living things or having biological components such as DNA. Bio computing is also used in bioinformatics to promote the biological research. Bio computing and biochemical pharmacology which uses biologically derived molecules such as Proteins and DNA. These are applied for computational calculations like storing data and therefore biocomputing is a part of nanotechnology. Nanotechnology also includes bio nanotechnology.  It is a branch of nanotechnology which uses biological resources or in biotechnology.

Track 4: Clinical Pharmacy

Good Clinical Practice is a set of procedures for biomedical studies which encompasses the design, conduct, termination, audit, analysis, reporting and documentation of the studies involving human subjects. It aims to confirm that the studies are systematically and virtuously sound and that the clinical properties of thepharmaceutical substances under investigation are properly documented. The guidelines seek to establish two cardinal principles: protection of the rights of human subjects. Clinical Therapeutics is dedicated to the dissemination of consistent and evolving evidence regarding therapeutics to an international audience of scientists and clinicians working in a diversity of research, academic, and clinical practice settings. This goal is especially important in an era of harmonization and globalization of drug improvement and genuineness ofbiomedical data generated. Randomised Clinical Trials are often used to test the efficacy or effectiveness of numerous types of medical drug interference and may provide info about adverse effects, such as drug reactions. Random assignment of intervention is done after subjects have been assessed for suitability and recruited, but before the intervention to be studied begins.

Track 5:  Pharmacology and Toxicology

It is the study of the interfaces that occur amid a living organism and compounds that affect regular or irregular biological function. Pharmacology, a biomedical science, deals with the research, discovery, and characterization of chemicals which show biological effects and the elucidation of cellular and original function in relation to these chemicals. With special focus on each sector the pharmacological sciences may be related to nerves, heart, hormones, kidneys, immune system, clinical features and the type of behaviour. The names were given relatively as neuro-pharmacology, cardiovascular drug pharmacology, endocrinology, uro-genital pharmacology, immunology, clinical pharmacology & behavioural pharmacology.

Track 6: Drug Safety Regulations

Drug Safety also known as Pharmacovigilance (PV or PhV), is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. In this Track discussion will be about the Drug safety and its applications in various fields such as softwares, Training etc. Canadian Society of Hospital PharmacistsChinese Pharmaceutical AssociationDanish Association of PharmaconomistsIndian Pharmacist AssociationThe Pharmaceutical Association of Israel

Track7: Pharmacy Practice

Pharmacy practice is the discipline of pharmacy which involves developing the professional roles of pharmacists. A drug interaction is a situation in which a substance (usually another drug) affects the activity of a drug when both are administered together. This action can be synergistic (when the drug's effect is increased) or antagonistic (when the drug's effect is decreased) or a new effect can be produced that neither produces on its own. Typically, interactions between drugs come to mind (drug-drug interaction). Drug addiction is a complex disease, and quitting takes more than good intentions or a strong will. In fact, because drugs change the brain in ways that foster compulsive drug abuse, quitting is difficult, even for those who are ready to do so. Therefore, drug stability and drug safety databases are also considered as key processes in clinical pharmacy.

Track 08Pharmacy Field

Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of Pharmaceutical drug. Pharmacy is a broad field and includes Pharmaceutical industry and Pharma marketing. Pharma marketing or Medico-marketing is the business of advertising or otherwise promoting the sale of pharmaceuticals or drugs. Emergences of new technology in recent years help in promotion. Pharmaceutical companies explore online marketing as an alternative way to reach physicians, their customers.

Track 09: Industrial Pharmacy

Pharmaceutical companies are engaged in the discovery, design, manufacturing, and marketing of legal drugs, biologics (viruses, toxins, serums, and analogous products), vaccines, and medical devices such as pacemakers and prosthetics. Products are made for both humans and animals. Drug discovery and development are important for any pharmaceutical industry to build up its economy. New molecules with new techniques of preparation at economical grade without compromising with quality is a major task to R&D. Various Clinical trials are to be done in different phases on animals, healthy and patient volunteers so as to estimate the suitability of the product formulation before it gets release to the market. Even after the formulation is released the Post marketing surveillance should be done to analyse the long term effects.

Track 10: Regulatory Authorities

Harmonisation achievements in the Quality area include pivotal milestones such as the conduct of stability studies, defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP) risk management. Intellectual property rights (IPR) have been defined as ideas, inventions, and creative expressions based on which there is a public willingness to bestow the status of property. IPR provide certain exclusive rights to the inventors or creators of that property, in order to enable them to reap commercial benefits from their creative efforts or reputation. There are several types of intellectual property protection like patent, copyright, trademark, etc. has Pharmaceutical Ethics concentrate on the promotion of medicine, which entails the regulations over many areas of the promotion of medicine. These include events and hospitality that can be extended by a pharmaceutical company.

Track 11 :Bio and Chemoinformatics

Bioinformatics plays key role in experimental molecular biology as image and signal processing allow extraction of useful results from large amounts of raw data. In the field of genetics and genomics, it aids in sequencing and annotating genomes and their observed mutations, in the text mining of biological literature and the development of biological and gene ontologies to organize and query biological data, in the analysis of gene and protein expression and regulation. Bioinformatics tools aid in the comparison of genetic and genomic data and more generally in the understanding of evolutionary aspects of molecular biology.

Chemoinformatics is a relatively new discipline, it has emerged from several older disciplines such as computational chemistry, computer chemistry, chemometrics, QSAR, chemical information, medicinalbiochemistry etc. Cheminformatics involves the use of computer technologies to process chemical data. Advent of high throughput screening (HTS), automated techniques have made possible robotized screening. In response to the increased demand for new compounds by biologists, chemists started using combinatorial chemical technologies to produce more new compounds in shorter periods. Another challenge faced by this new field was to establish clear relationships between structural patterns and activities or properties, chemoinformatics should be able to extract knowledge from large-scale raw HTS databases in a shorter time periods, chemoinformatics should be able to provide efficient in silico tools to predict ADMET properties. One of the earliest chemoinformatics studies involved chemical structure representations, such as structural descriptors. Pharmaceutical Society of Australia;The Pharmacy Guild of Australia;The Society of Hospital Pharmacists of Australia;Canadian Pharmacists Association;Canadian Society of Hospital Pharmacists;Chinese Pharmaceutical Association

Track 12: Market analysis and Business Opputunity

According to IMS Health Consulting, an international research company, in 2012 the size of the global pharmaceutical market reached $940 billion. In monetary terms it grew by 6%. In the future the sector is expected to grow at no less than 3% to 4% a year and if this happens the global pharmaceutical market is expected to reach $1.1 trillion by 2015 and will reach $1.2 trillion in 2016 and up to $1.5 trillion by 2020. The global demographic, epidemiological and economic changes are transforming the pharmaceutical market. The world population is growing rapidly and is projected to rise from 7 billion in 2011 to 7.7 billion in 2020 and 9.6 billion in 2050, hence an increase in the demand for pharmaceuticals.The ageing process also affects the demand. By 2020 about 9.4% of the world population (719.4 million people) will be 65 or above, compared with 7.3% (477.4 million) in 2005 (UN, 2013). Clinical advances reinforce this trend. The improvements of the past few decades have already converted some previously terminal illnesses into chronic conditions, thus increasing long-term demand for pharmacotherapeutics to manage these diseases. Spending on medicines will reach nearly $1,100Bn in 2015, reflecting a slowing growth rate of 3-6% over the five year period compared to 6.2% annual growth over the past five years. Absolute global spending growth is expected to be $210-240Bn, compared to $251Bn since m2005.

Track 13: Entrepreneurs Investment Meet

Global Pharma Summit is a productive conclave focussing in collaboration and communication among the Pharma Professional Business Entrepreneurs and Pharma Industrial Persons. Meetings fall apart thanks to sloppy agendas in making their annual planning about developing their Business. Here's how some of the world's top execs participate in this congress and share their views and ideas.

Conference Series LLC  invites all the participants from all over the world to attend ‘8th Annual Global Pharma Summit’, during August 22-24, 2016 in San Francisco, USA which includes prompt keynote presentations, Oral talks, Poster presentations, Workshops and Exhibitions.

American Pharma-2017 is a global conclave delving  New Insights and Recent Advancements in Pharmaceutical Sciences. It is a pavement for pharma experts and scientific professionals to explore the Research Challenges & Current Trends and enleash advanced strategies in the arena of Pharma Research.

Why to attend???

With all the scientific people over the world focused on learning about Pharmaceutical Current and Novel trends and advanced strategies in Pharma Technology.This is a best globalised opportunity to reach the largest assemblage of participants from the Pharma community. We anticipate participants, renowned speakers and eminent delegates across the globe attending the conference to share their valuable presentation and galvanize the scientific community. Pharma-2016 is a 3-day event offering the Exhibition at venue to showcase the new and emerging technologies and Conduct presentations, distribute information, meet with potential scientists, make a splash with new drug developments, and receive fame and recognition. Our services have always met with great achievement in Business Conferencing. World-renowned speakers, the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Target Audience:

  • Eminent Scientific Professionals in Pharma
  • Faculty (Professors,Associate Professors,Asst Professors )
  • Pharma Colleges & Training Institutes
  • Pharmaceutical  Associations and Societies
  • Pharmaceutical Business Entrepreneurs
  • Manufacturing Pharmaceutical products Companies
  • Manufacturing Medical Devices Companies
  • Professors, Associate Professors, Asst Professors
  • Pharmaceutics Students
  • PhD Scholars, Graduates and Post Graduates
  • Directors, CEO’s of Organizations
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Research Institutes and members
  • CRO and DATA management Companies
  • Data Management Companies

SummaryAmerican Pharma 2017 is a specially designed cluster conference and would lay a platform for  the interaction among specialists, directors, professors, faculties, experts, and research fellows around the world reputed research institutes, universities and companies, agencies, association & societies.It aims in accelerating the scientific discoveries in the field of Pharmaceutical Studies to exchange information on their latest research progress.We are glad to have your presence at ‘8th Annual Global Pharma Summit’ scheduled to be held during August 17-18, 2017 San Francisco, USA. The organizing committee is gearing up for an exciting and informative event procuring plenary lectures, symposia, workshops on a variety of topics, poster presentations and various sessions for participants from all over the world. All the members of American Pharma 2017 organizing committee look forward to meet you at San Francisco, USA.

For more details please visit-

Scope and Importance: The market environment in which Pharmaceutical and Life Sciences companies operate is increasingly challenging, being driven by a more and more demanding healthcare agenda leading to a new marketing and sales system The global need for innovative, cost effective medicines continues to rise whilst regulators , payers, health care providers and patients are demanding greater value for money, proven effectiveness of products, more transparency and access to information. To meet these demands companies are seeking ways to improve R&D productivity, increase the efficiency of its operations, rationalise spending on sales and marketing and enhance financial performance. Marketing the future, wide range of pharmaceutical and life sciences companies to address the major challenges they face in R&D, supply chain, sales and marketing across the full spectrum of corporate functions.

The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. Companies will need to demonstrate that their brand adds value to patients and they will have to offer a package of products and health services that the market not only wants and needs but is willing to pay a premium for. The paper highlights some very strong facts related to the need for Pharma to change its marketing and sales functions to sustain future growth and performance.

Why San Francisco, USA?

 The global market for drugs Pharmaceutical Drugs and poducts is estimated to be $181.9 billion in 2013. In 2018,  revenues are estimated to reach nearly $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.The United States is the world’s largest market for pharmaceuticals and the world leader in biopharmaceutical research.The biopharmaceutical pipeline also has over 5,000 new medicines currently in development around the world with approximately 3,400 compounds currently being studied in the United States. New Orleans is a home of many pharmaceutical companies such as  Syncor International,Pharmanex, Alpha Pharmaceutical, Mumfrey's Pharmacy, Zenas Technologies, HALIX Contract Manufacturers. New Orleans is famous tourist Destination Nicknamed the “Big Easy,” it’s known for its French, African and American Cultures. San Francisco ranks first in ten classifications of “America’s Favorite Cities”.The city is regularly alluded to as the “most unique” in the United States. 

Conference Highlights

  • Pharmaceutical Preformulation
  • Novel Drug Delivery Systems
  • Pharma Nanotechnology
  • Clinical Pharmacy
  • Pharmacology and Toxicology
  • Pharmacognosy and Phytochemistry
  • Pharmacy Practice
  • Medicinal Chemistry
  • Industrial Pharmacy
  • Regulatory Authorities
  • Market analysis and Business opportunity
Global Market For Contract Pharmaceutical Manufacturing, Research And Packaging By Segment, 2012-2019 ($ BILLIONS)


Major Pharma Associations and Societies:

  • American Association of Colleges of Pharmacy
  • American Pharmacists Association
  • American Society of Consultant Pharmacists Foundation
  • American Society of Consultant Pharmacists (ASCP)
  • American Pharmacists Association
  • American Society of Consultant Pharmacists Foundation
  • American Society of Health-System Pharmacists
  • Professional Compounding Centers of America
  • Association of Pharmacy Professionals
  • Pharmaceutical Society Of New Zealand
  • Pharmaceutical Association of Mauritius
  • International Pharmaceutical Federation (FIP)
  • Canadian Pharmacists Association
  • Royal Pharmaceutical Society (RPS)

Major Pharma Companies in USA

  • Pfizer
  • Johnson & Johnson
  • Abbott Laboratories
  • Merck & Co.
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Amgen
  • Baxter International
  • AbbVie
  • Genzyme
  • Allergan
  • Gilead Sciences
  • Biogen Idec
  • Mylan Laboratories
  • Eli Lilly & Co.
  • Abbott Laboratories
  • McKesson
Pharmaceutical market Growth:  
Global market for single-use technologies used in the manufacture of biopharmaceuticals by geographic region, 2011-2017 ($ millions)  

Major Universities in USA

  • Samford University
  • The University of Arizona
  • The University of Iowa          
  • Harding University
  • University of Pennsylvania    
  • Touro University California
  • The State University of New Jersey  
  • Regis University
  • Howard University

Funding organizations for Research:

  • DST: Department of Science and Technology
  • CPF: Community Pharmacy Foundation
  • UCSF: University of California, San Francisco
  • CVS Health Foundation
  • National Community Pharmacists Association Foundation Scholarships
  • AACP: American Association of colleges of Pharmacy
  • Pre-Doctoral Fellowships in Pharmaceutical Science
Pharmaceutica 2016

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Pharma2016 a wonderful event!

OMICS International hosted 7th Annual Global Pharma Summit was scheduled during August 22-24, 2016 at Hilton New Orleans Airport, United States with the theme “Reviving New Aspects and Advanced Strategies in Pharmaceutical Sciences"

The conference had several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various Professors, Pharma Companies, Researchers, students and leaders from the fields of Pharmacy and Health Care Business and Research Professionals, who made this event a Grand Success.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

·         Pre-Formulation Studies

·         Bio-Pharmaceutical Sciences

·         Novel Drug Delivery Systems

·         Industrial Pharmacy

·         Drugs and Medical Devices:  Regulatory affairs

·         Pharmacological Sciences

·         Pharmacognosy and Phytochemistry

·         Current trends in Pharma- Nanotechnology

·         Pharmacogenetics

·         Pharmaceutical Ethics & IPR

·         Bioinformatics in Health Care System

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

·        Thomas Laurence Richie, Sanaria Inc., USA

·        Patsy Lewis, USA

·        John Yu, Chang Gung Memorial Hospital, Taiwan

·        Ying Li, City University of Hong Kong, Hong Kong

Series of special sessions include expert presentation by Dr Ying Li, City University of Hong Kong, Hong Kong., “Brainstem-cortex synaptic plasticity in the trigeminal neuropathic pain” and Dr Lorand Kiss, University of Szeged, Hungary on “Selective synthesis of fl uorinated cyclic -amino acid scaffolds

OMICS International offers its heartfelt appreciation to the Organizing Committee Members, namely Dr. Robert C. SizemoreDr. George Perry, who supported us throughout the event. Also, it would be incomplete without thanking all our expert presenters from all around the world which includes various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums.

With the grand success of Pharma-2016, OMICS International is proud to announce the “8thAnnual Global Pharma Summit 2017" to be held during August 17-18, 2016 at Los Angeles, USA.

For More details visit:


Past Reports  Gallery  

Click here to submit abstract to any of the above topics


Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 17-18, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Conferenceseries Destinations